Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial | Noticias Tech y Ciencia Actualizadas
Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial The interim Phase I trial data was only from 35 people, but results look good so far. The interim Phase I trial data was only from 35 people, but results look good so far. Detalles clave Fuente confiable Actualizado recientemente Impacto relevante… Leer más »